EN DE
STOCK COMPARISON

Erie Indemnity vs Marsh & McLennan Companies: Fair Value & Quality

Both stocks run through our valuation models. Here is how Erie Indemnity (ERIE) and Marsh & McLennan Companies (MRSH) compare, as of Aug 8, 2026.

As of Aug 8, 2026, Fair Value Calculator sees Erie Indemnity as the less overvalued of the two: Erie Indemnity trades at $254 versus a fair value of $157 (-38%), while Marsh & McLennan Companies trades at $193 versus $112 (-42%).
Erie Indemnity
ERIE · USD · Financials
-38%
upside to fair value
overvalued
Price$254
Fair Value$157
Quality56/100
Marsh & McLennan Companies
MRSH · USD · Financials
-42%
upside to fair value
overvalued
Price$193
Fair Value$112
Quality63/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Erie IndemnityMarsh & McLennan Companies
Valuation
20.7×P/E (TTM)22.8×
2.91×P/S (TTM)3.19×
5.21×P/B5.81×
14.1×EV/EBITDA13.6×
2.67×PEG1.76×
2.5%Dividend yield2.0%
$5.66Dividend per share$3.60
Profitability
14%Net margin14%
17%Operating margin24%
26%Return on equity28%
15%Return on assets7%
Growth
2%Revenue growth (YoY)8%
12.7%Avg. growth/yr (3Y)9.2%
9.6%Avg. growth/yr (5Y)9.4%
Balance & size
0.04×Debt / equity1.21×
$12BMarket cap$88B
healthyGrowth qualityhealthy

Erie Indemnity leads: 8 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Erie Indemnityof which business quality 62 · market factors 43 Marsh & McLennan Companiesof which business quality 60 · market factors 57
ProfitabilityMargins and returns on capital today
73
55
Quality GrowthAre margins and returns improving?
24
50
CashflowEarnings quality: real cash, not paper profit
64
75
Fin. StrengthBalance sheet, leverage, solvency risk
83
35
InvestmentDisciplined investing over empire-building
47
62
Low VolatilityCalm price path (market factor)
76
84
MomentumPrice trend over the last 3–12 months (market factor)
36
44
52W MomentumDistance to the 52-week high (market factor)
17
50
Net IssuanceBuybacks instead of dilution
58
93

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Erie Indemnity

DCF Models$234
Earnings-Based$116
Dividend Discount$95.93
Multiples$219
Asset-Based$33.12
Growth DCF$228
Economic Profit$132
Growth Earnings$222

23 of 26 models see the stock below the current price.

Marsh & McLennan Companies

DCF Models$145
Earnings-Based$67.56
Dividend Discount$60.10
Multiples$150
Asset-Based$21.00
Growth DCF$135
Economic Profit$86.32
Growth Earnings$152

25 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Erie Indemnity
Bear $118Fair Value $157Bull $197
$254 = current price (white tick)
Marsh & McLennan Companies
Bear $84.19Fair Value $112Bull $140
$193 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Erie Indemnity · Financials

Quality score56 · below median
Fair value upside-38% · below median

Marsh & McLennan Companies · Financials

Quality score63 · above median
Fair value upside-42% · bottom 25%

Bottom line

As of Aug 8, 2026, Fair Value Calculator sees Erie Indemnity as the less overvalued of the two: Erie Indemnity trades at $254 versus a fair value of $157 (-38%), while Marsh & McLennan Companies trades at $193 versus $112 (-42%).

Marsh & McLennan Companies has the higher quality score (63/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.